Oncology APIs DMF Status Azacitidine USDMF 27487 Bendamustine

Oncology API’s DMF Status Azacitidine USDMF # 27487 Bendamustine HCl USDMF # 25222 Bicalutamide USDMF# 24690 Bortezomib Capecitabine USDMF# 24944 R 0 -CEP 2011 -339 -Rev 01, USDMF# 25491 USDMF# 24689 Decitabine USDMF # 27488 Erlotinib HCl USDMF # 29124 CEP R 0 -CEP 2006 -222, USDMF # 24136 USDMF # 27927 Busulfan Gemcitabine HCl Imatinib Mesylate Irinotecan HCl Trihydrate Letrozole Melphalan HCl USDMF # 23562 R 0 -CEP 2013 -321 -Rev 00, USDMF # 27489 USDMF # 28930 Oxaliplatin Pemetrexed Dipotassium Nona hydrate Pemetrexed Disodium Hemipentahydrate Temozolomide R 0 -CEP 2006 -201, USDMF # 23563 Zoledronic acid USDMF # 25905 Anastrozole DMF available Axitinib DMF available Clofarabine DMF available Abiraterone Acetate Tech. Pack available Cabazitaxel Tech. Pack available Cladribine Tech. Pack available Cyclophosphamide Tech. Pack available Cytarabine Tech. Pack available Dasatinib Monohydrate Tech. Pack available Docetaxel Tech. Pack available Enzalutamide Tech. Pack available Gefitinib Tech. Pack available Lenalidomide Tech. Pack available Paclitaxel Tech. Pack available Regarofinib Tech. Pack available Sorafenib Tosylate Tech. Pack available Sunitinib Tech. Pack available DMF available USDMF # 25102 USDMF # 23479 Products covered by valid patents in any country are not offered or supplied to those countries.

Non-Oncology API’s DMF Status Ambroxol HCl R 1 -CEP 2004 -201 Rev 02 Fingolimod HCl USDMF # 28162 Phenylephrine HCl CEP 2012 -060 Acebrophylline DMF available Nifedipine DMF available Sildenafil Citrate DMF available Dimethyl Fumarate DMF available Pirfenidone Teck Pack available Prucalopride Succinate Teck Pack available Ursodeoxycholic acid (from our Italian Principal) ARV List DMF Status Tenofovir DMF available Emtricitabine Teck Pack available Elvitegravir Teck Pack available Cobicistat Teck Pack available Under Development-Oncology API’s Afatinib Dimaleate Bosutinib Carfilzomib Ibrutinib Crizotinib Lapatinib Distosylate Mecitentan Odanacatib Nintedanib Nilotinib Pomalidomide Vemurafenib Vismodegib For enquiries, please contact Shilpa Medicare Limited 10/80, Rajendra Gunj, Raichur – 584 102 (India) Tel: +91 -8532 -235006, Fax: +91 -8532 -235876 e. Mail: vishnu@vbshilpa. com, Web: www. vbshilpa. com Products covered by valid patents in any country are not offered or supplied to those countries.